Cigna Group stock
Price history
+9.64% over the period1 year: from $270.89 (November 13, 2025) to $297.00 (November 13, 2026), +9.64%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 13, 2026 | $297.00 |
| October 30, 2026 | $298.23 |
| September 30, 2026 | $271.83 |
| August 31, 2026 | $276.08 |
| July 31, 2026 | $279.05 |
| June 30, 2026 | $275.68 |
| May 29, 2026 | $277.40 |
| April 30, 2026 | $290.58 |
| March 31, 2026 | $266.75 |
| February 27, 2026 | $289.82 |
| January 30, 2026 | $274.11 |
| December 31, 2025 | $275.23 |
| November 28, 2025 | $277.28 |
| November 13, 2025 | $270.89 |
At a glance
The company
Provides health insurance, pharmacy benefit management and related healthcare services in the U.S. and internationally
Latest results
Quarter to September 30, 2026 · EPS $7.98 (estimate $7.52)
Next event
Dividend
TickerLandia's take on Cigna Group
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 13 vs a median of 16 over its last 10 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 13 vs 18 (−28%) in a group of 7.
- Strong point: Earnings stability (73/100 in its group). Weak point: Profitability (36/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−6.62% from the 52-week high
Analysts · 24 analysts
Average target$344.96+16.15% vs. price
Buy 17 · Hold 7 · Sell 0 · Buy
TickerLandia Fingerprint: Cigna Group
Compared with similar companies: very low price and very low risk.
Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 883 North American stocks.
Pricevery low14
How much it costs relative to what it produces.
Metric Value Position in group Price/sales 0.27 13 Forward P/E 8.93 6 EV/EBITDA 8.04 16 Price/book 1.81 21 P/E (trailing 12 months) 13.1 14 Profitabilitylow36
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 3.8% 28 ROE 15.6% 66 ROA 4.3% 42 Net margin 2.1% 31 Gross margin 9.1% 10 Earnings stabilityhigh73
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 0.5% 88 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 59 Growthaverage44
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +5.60% 40 Average revenue growth (3 years) +15.05% 74 Earnings growth (year over year) −21.60% 18 Financial strengthaverage47
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 1.97 55 Current ratio 0.84 19 Interest coverage 7.33 60 Debt/equitycounts in reverse: lower means more financial strength 0.71 52 Dividendhigh66
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 37 years 95 Payout ratio 27.3% 39 Dividend yield 2.1% 64 Market momentumaverage53
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (6 months) −2.77% 38 Relative strength (3 months) +10.19% 74 Distance from 200-day average +5.01% 56 1-year return +9.64% 45 Riskvery low18
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 12.8% 5 Beta (1 year) 0.09 22 Volatility (60 days) 25.6% 26
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Cigna Group is cheaper than in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), Cigna Group's P/E today is 13.4, below the median of its last 10 fiscal years (16.3; between 9.07 and 23.2 from 2016 to 2025). Cigna Group's P/E (trailing 12 months): 13.1, −28% against the median of a group of 7 similar companies (18.3).
Compared with 7 similar companies
| Metric | Cigna Group | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 13.1 | Middle | |
| Forward P/E | 8.93 | Low | |
| Operating margin | 3.8% | Middle | |
| ROE | 15.6% | Middle | |
| Debt/equity | 0.71 | High |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Cigna Group. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$71.67B
Latest quarter · Q2 2026
Net income
$1.66B
Latest quarter · Q2 2026
Quarterly net margin
2.3%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- $78.26B
- P/E
- 13.1
- EPS
- $22.68
- Volume
- 1.44M
- Daily trading
- €456M
- Dividend yield
- 2.08%
How Cigna Group is changing
All resultsRevenue grew 11.4% a year on average over the last 5 years
Operating margin fell from 4.8% to 3.7%
Profits turn into cash: free cash flow equal to 190% of net income
Returns
Cigna Group returns with dividends
$1,000 invested in Cigna Group 5 years ago, on November 15, 2021, would be worth $1,512 today with dividends reinvested: +51.21% in total, +8.63% per year. On price alone it would be $1,378 (+37.80%).
| Period | Cigna Group | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +5.12% | −3.12% | $1,051 |
| 6 months | −1.23% | +1.58% | $988 |
| Year to date | +7.91% | +10.46% | $1,079 |
| 1 year | +12.11% | +12.23% | $1,121 |
| 3 years | +7.02% | +71.41% | $1,070 |
| 5 years | +51.21% | +61.48% | $1,512 |
| 10 years | +142.75% | +249.40% | $2,427 |
Over the last 6 months it has done better than 20% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Cigna Group: technical analysis
Cigna Group is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 19.0% below its highest close since January 2, 1990 ($366.85, September 16, 2024).
- Trend
- Upward
- RSI (14 sessions)
- 51
- Between 30 and 70
- vs 200-session average
- +5.01%
Support and resistance
Price areas where Cigna Group has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$317.16+6.79%2 touches, last on November 5, 2026
- Resistance$304.49+2.52%3 touches, last on July 28, 2026
- Resistance$297.02+0.01%4 touches, last on June 12, 2026
- Last price$297.00
- Support$288.97−2.70%6 touches, last on September 14, 2026
- Support$279.31−5.96%6 touches, last on July 16, 2026
- Support$272.69−8.19%8 touches, last on September 9, 2026
Volatility and risk
Over the last year it has moved little with the S&P 500.
- Beta (1 year) vs S&P 500
- 0.09
- Volatility (60 sessions, annualised)
- 25.6%
- Largest fall in the last year
- −12.81%
Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Cigna Group: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for Cigna Group has been November: +5.59% on average, positive in 28 years out of 36. The weakest has been September: −1.28% on average, positive in 17 years out of 37.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +2.13% | +3.42% | 23 of 36 |
| February | +0.62% | +0.21% | 20 of 37 |
| March | +1.48% | +0.77% | 21 of 37 |
| April | +1.45% | +2.43% | 22 of 37 |
| May | +2.52% | +2.93% | 22 of 37 |
| June | +0.71% | +1.49% | 23 of 37 |
| July | −0.72% | −0.97% | 15 of 37 |
| August | +1.59% | +1.84% | 21 of 37 |
| September | −1.28% | −1.54% | 17 of 37 |
| October | −0.43% | +0.57% | 20 of 37 |
| November | +5.59% | +7.33% | 28 of 36 |
| December | +2.48% | +0.31% | 21 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Cigna Group and its competitors
Evernorth and Cigna Healthcare are the names behind the activities of The Cigna Group, a US company that sells insurance and related services mainly in the United States. Evernorth covers pharmacy benefit management, claims processing, home delivery and specialty pharmacy, along with clinical programs aimed at overall health. Cigna Healthcare offers employer medical plans, individual and family coverage, behavioral health, dental, stop-loss insurance and health benefits for mobile workers and the staff of multinational firms. Other operations include corporate-owned life insurance and reinsurance.
- Headquarters
- Bloomfield, United States
- Employees
- 65,669
- Founded
- 1792
- Chief executive
- Brian Evanko
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Cigna GroupCI | $78.26B | 3.8% | 13.1 | −1.23% |
| Elevance HealthELV | $92.88B | 4.0% | 18.3 | +7.52% |
| HumanaHUM | $50.12B | 2.3% | 39.0 | +47.61% |
| CVS HealthCVS | $114.32B | 3.1% | 10.4 | −8.93% |
| CenteneCNC | $33.52B | 1.9% | 22.8 | +21.19% |
| UnitedHealth GroupUNH | $365.09B | 5.9% | 23.3 | +1.57% |
Same industry or related industries, similar size. Compare Cigna Group with its competitors · Full profile
